Ceylinco Healthcare Services Limited (CHSL) has announced the appointment of senior Consultant Oncologist Dr. Sarath Abeyakoon to the company’s Board of Directors.
One of Sri Lanka’s most senior medical professionals in the field of Oncology, Dr. Abeyakoon MBBS, MD has served as Senior Oncologist and Medical Director of the Ceylinco Radiation Treatment Centre since 2007.
The Centre, which introduced state-of-the-art Linear Accelerator technology to the country for the treatment of cancer, is one of three facilities owned and managed by CHSL, a wholly-owned subsidiary of life insurance leader Ceylinco Life.
The other two facilities are the Ceylinco Healthcare Centre and the Ceylinco Diabetes Centre.
Trained in Sri Lanka and at the Royal London Hospital, Whitechapel, UK, Dr. Abeyakoon counts more than 20 years of experience as a senior consultant in the field of Oncology, and has served as Consultant Oncologist at the Maharagama Cancer Hospital, the country’s largest facility for the treatment of cancer.
He was also the Senior Specialist Medical Officer in charge of the Cancer Unit at the ANGAU Memorial Hospital in Papua New Guinea for three years. From 2003 to 2006, Dr. Abeyakoon served as Chairman of the Board of Study in Clinical Oncology in Sri Lanka. He was awarded the Presidential Award for Scientific Research in 2010.